Stoke Therapeutics, Inc.
Antisense oligomers and uses thereof

Last updated:

Abstract:

Provided herein are methods and compositions for increasing the expression of a protein, and for treating a subject in need thereof, e.g., a subject with deficient protein expression or a subject having a disease described herein.

Status:
Grant
Type:

Utility

Filling date:

13 Jun 2018

Issue date:

24 Aug 2021